Analytical reference standards · Impurity / metabolite / stable-isotope products · Worldwide shipping
Quotation within 1 business day · sales@aurstandards.com
Request quotation
Home/Products/ Alimentary tract and metabolism/ Linagliptin/(R,Z)-8-(3-aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1…

(R,Z)-8-(3-aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione

CAS 1638744-06-5 L0001-0573 API: Linagliptin Parent API approved (FDA / EMA) 1 stereocentre, R/S assigned

Structure

Click to enlarge
2D structure generated from the SMILES string registered for this item. 1 stereocentre is defined and annotated (R/S). 1 double bond drawn with defined E/Z geometry. Click the image to enlarge.
i

Stereochemistry. Absolute configuration R — assignment by CIP rules on the depicted structure. InChIKey KOVUTSTYXMWMHQ-XBNGYDHASA-N. Configuration is a property of the substance, not of a particular lot; it is confirmed by the synthetic route and by chiral HPLC or NMR where applicable.

Identity

Catalogue numberL0001-0573
CAS Registry Number1638744-06-5
Molecular formulaC25H29BrN8O2
Molecular weight553.47 g/mol
InChIKeyKOVUTSTYXMWMHQ-XBNGYDHASA-N
Parent APILinagliptin — ATC A10BH05
Therapeutic areaAlimentary tract and metabolism (A)
Compound classRelated substance
Stereocentres1 — configuration R
PurityBatch-specific — stated on the COA
Appearance / formConfirmed on quotation
StorageDesiccated, protected from light (see COA)
ShippingAmbient with desiccant; dry ice on request
CC1=NC(=NC2=CC=CC=C12)CN3C(=O)C4=C(N=C(N4C/C=C(/C)\Br)N5CCC[C@H](C5)N)N(C3=O)C

Supply options

Pack sizesQuoted per request (mg to gram scale)
Lead timeConfirmed on quotation
DocumentationCOA, MS, 1H NMR, HPLC on request
Custom synthesisAvailable for scale-up and labelled analogues

Frequently asked questions

What documentation is supplied with L0001-0573?

Each lot is released with a certificate of analysis stating identity, assay or purity by HPLC, water content and residual solvents where applicable, plus the storage recommendation and re-test date. Mass spectra and NMR data are available on request before ordering.

How is (R,Z)-8-(3-aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1… characterised?

Identity is established by mass spectrometry and NMR, with chromatographic purity by HPLC. The structure published above is generated from the registered SMILES string and carries 1 CIP-assigned stereocentre. The CAS registry number 1638744-06-5 links this item to the published literature.

Can the pack size, salt form or labelling be customised?

Yes. Labelled analogues (13C, 15N, D), alternative salt forms and larger pack sizes are quoted separately. Send the target structure or SMILES and we will confirm feasibility and lead time.

Do you ship internationally?

Yes, worldwide, with commercial invoice and safety data sheet. Shipments leave with desiccant and temperature protection; dry ice is available on request.

Request this standard

Send your requirement — we reply with availability, purity data and price within one business day.

Your details are used only to answer this inquiry. No newsletter, no third-party sharing.